Data / Form D filings / KUROBE PHARMACEUTICALS, INC.
KUROBE PHARMACEUTICALS, INC.: Form D filing
KUROBE PHARMACEUTICALS, INC., a pharmaceuticals company in Tampa, FL, filed a Form D with the SEC in 2013. The latest, on June 4, 2013, reports $5 million sold of a $6 million offering to 3 investors.
Find out what KUROBE PHARMACEUTICALS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 400 N ASHLEY DRIVE, SUITE 2150, Tampa, FL, 33602
- Phone
- (813) 579-2550
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2012
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1578486
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 4, 2013 | New notice | $6,000,000 | $5,000,000 | $1,000,000 | 3 | May 21, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sean Ianchulev | Director | |
| BARRY BUTLER | Executive Officer, Director | |
| Eiji Katayama | Director | |
| Curt LaBelle | Director | |
| Yvonne Gallimore | Executive Officer | |
| Haley Butler | Executive Officer | |
| Naohito Takahashi | Director |
Other pharmaceuticals companies in Florida that filed recently
- GOA Therapeutics Corp $300,000 · Nov 5, 2026
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Jun 3, 2013 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what KUROBE PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.